Cited by

• Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

  Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI. Kollef MH, et al. Clin Infect Dis. 2011 Sep;53 Suppl 2(Suppl 2):S33-55; quiz S56-8. doi: 10.1093/cid/cir475. Clin Infect Dis. 2011. PMID: 21868447 Free PMC article. Review.
• Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

  Russo A, Giuliano S, Ceccarelli G, Alessandri F, Giordano A, Brunetti G, Venditti M. Russo A, et al. Antimicrob Agents Chemother. 2018 May 25;62(6):e02562-17. doi: 10.1128/AAC.02562-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29555630 Free PMC article.
• Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India.

  Williams A, Mathai AS, Phillips AS. Williams A, et al. J Pharm Bioallied Sci. 2011 Oct;3(4):531-6. doi: 10.4103/0975-7406.90108. J Pharm Bioallied Sci. 2011. PMID: 22219587 Free PMC article.
• Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study.

  Russo A, Bassetti M, Bellelli V, Bianchi L, Marincola Cattaneo F, Mazzocchetti S, Paciacconi E, Cottini F, Schiattarella A, Tufaro G, Sabetta F, D'Avino A. Russo A, et al. Infect Dis Ther. 2021 Mar;10(1):187-200. doi: 10.1007/s40121-020-00357-8. Epub 2020 Oct 17. Infect Dis Ther. 2021. PMID: 33068255 Free PMC article.
• Simultaneous use of other antimicrobials may have influenced clinical outcomes.

  McKinnell JA, Eells SJ, Wang AA, Miller LG. McKinnell JA, et al. Clin Infect Dis. 2011 May;52(10):1279; author reply 1279-80. doi: 10.1093/cid/cir135. Clin Infect Dis. 2011. PMID: 21507927 Free PMC article. No abstract available.